US Bancorp’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4K Buy
52
+11
+27% +$2.27K ﹤0.01% 3342
2025
Q4
$8.47K Buy
41
+21
+105% +$4.2K ﹤0.01% 3387
2025
Q3
$3.59K Sell
20
-50
-71% -$8.52K ﹤0.01% 3629
2025
Q2
$11.3K Buy
70
+50
+250% +$7.96K ﹤0.01% 3387
2025
Q1
$3.4K Hold
20
﹤0.01% 3762
2024
Q4
$3.32K Hold
20
﹤0.01% 3744
2024
Q3
$3.44K Sell
20
-52
-72% -$8.61K ﹤0.01% 3673
2024
Q2
$11.1K Buy
72
+53
+279% +$7.95K ﹤0.01% 3271
2024
Q1
$2.92K Sell
19
-132
-87% -$20.1K ﹤0.01% 3649
2023
Q4
$23.9K Sell
151
-32
-17% -$4.6K ﹤0.01% 2975
2023
Q3
$26.8K Buy
183
+13
+8% +$1.98K ﹤0.01% 2738
2023
Q2
$26K Hold
170
﹤0.01% 2842
2023
Q1
$26.4K Sell
170
-608
-78% -$95.5K ﹤0.01% 2841
2022
Q4
$120K Buy
778
+740
+1,947% +$109K ﹤0.01% 2118
2022
Q3
$5K Hold
38
﹤0.01% 3587
2022
Q2
$5K Sell
38
-24
-39% -$3.31K ﹤0.01% 3579
2022
Q1
$9K Sell
62
-28
-31% -$4.14K ﹤0.01% 3403
2021
Q4
$15K Sell
90
-190
-68% -$30.7K ﹤0.01% 3260
2021
Q3
$46K Sell
280
-1,329
-83% -$227K ﹤0.01% 2696
2021
Q2
$278K Buy
1,609
+259
+19% +$42.8K ﹤0.01% 1837
2021
Q1
$217K Sell
1,350
-87
-6% -$14.9K ﹤0.01% 1889
2020
Q4
$241K Sell
1,437
-239
-14% -$38.8K ﹤0.01% 1794
2020
Q3
$264K Buy
1,676
+243
+17% +$39.7K ﹤0.01% 1640
2020
Q2
$240K Buy
1,433
+1,272
+790% +$200K ﹤0.01% 1659
2020
Q1
$21K Sell
161
-247
-61% -$35.2K ﹤0.01% 2727
2019
Q4
$61K Sell
408
-394
-49% -$54.1K ﹤0.01% 2380
2019
Q3
$99K Buy
802
+453
+130% +$60.3K ﹤0.01% 2162
2019
Q2
$49K Hold
349
﹤0.01% 2536
2019
Q1
$53K Sell
349
-15
-4% -$2.16K ﹤0.01% 2463
2018
Q4
$46K Buy
364
+54
+17% +$7.38K ﹤0.01% 2486
2018
Q3
$49K Hold
310
﹤0.01% 2563
2018
Q2
$43K Sell
310
-53
-15% -$7.28K ﹤0.01% 2648
2018
Q1
$48K Hold
363
﹤0.01% 2639
2017
Q4
$45K Hold
363
﹤0.01% 2642
2017
Q3
$45K Hold
363
﹤0.01% 2613
2017
Q2
$42K Sell
363
-140
-28% -$15.1K ﹤0.01% 2620
2017
Q1
$53K Buy
503
+40
+9% +$4.01K ﹤0.01% 2454
2016
Q4
$42K Sell
463
-246
-35% -$23K ﹤0.01% 2532
2016
Q3
$71K Sell
709
-600
-46% -$58.9K ﹤0.01% 2261
2016
Q2
$117K Sell
1,309
-4
-0.3% -$367 ﹤0.01% 1960
2016
Q1
$115K Sell
1,313
-2,590
-66% -$228K ﹤0.01% 1936
2015
Q4
$441K Buy
3,903
+727
+23% +$78.3K ﹤0.01% 1360
2015
Q3
$322K Buy
3,176
+888
+39% +$106K ﹤0.01% 1501
2015
Q2
$284K Buy
2,288
+119
+5% +$14.4K ﹤0.01% 1612
2015
Q1
$257K Buy
2,169
+215
+11% +$24.3K ﹤0.01% 1681
2014
Q4
$200K Buy
1,954
+1,016
+108% +$99.2K ﹤0.01% 1772
2014
Q3
$86K Buy
938
+764
+439% +$66.3K ﹤0.01% 2187
2014
Q2
$14K Buy
+174
New +$13.3K ﹤0.01% 2969

Other funds holding FBT

US Bancorp's FBT Position: Q1 2026 in Review

US Bancorp increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 27% in Q1 2026, buying an estimated $2.27K and bringing the position to 52 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3342.

US Bancorp first reported a position in FBT in Q2 2014 and has held it in 48 quarters since. The position peaked at $441K in Q4 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • US Bancorp held 52 shares of First Trust NYSE Arca Biotechnology Index Fund worth $10.4K as of Q1 2026.
  • US Bancorp bought 11 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.27K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3342 holding.
  • US Bancorp first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and has held it in 48 quarters since.
  • US Bancorp's First Trust NYSE Arca Biotechnology Index Fund position peaked at $441K in Q4 2015.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.